Neutra Corp. (NTRR)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 16, 2026, 9:30 AM EST
Neutra Market Cap
Neutra has a market cap or net worth of $608.58 thousand as of January 21, 2026. Its market cap has increased by 108.57% in one year.
Market Cap
608.58K
Enterprise Value
672.66K
Revenue
66.07K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 13, 2011, Neutra's market cap has decreased from 15.60M to 608.58K, a decrease of -96.10%. That is a compound annual growth rate of -20.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 608.58K | 100.00% |
| Dec 31, 2025 | 304.29K | -33.87% |
| Dec 31, 2024 | 460.14K | -47.43% |
| Dec 29, 2023 | 875.37K | -4.88% |
| Dec 30, 2022 | 920.29K | -56.97% |
| Dec 31, 2021 | 2.14M | -3.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 782.06M |
| Glass House Brands | 715.55M |
| Elite Pharmaceuticals | 505.65M |
| Northwest Biotherapeutics | 472.88M |
| Nika Pharmaceuticals | 395.06M |
| American Oncology Network | 386.20M |
| CytoDyn | 328.21M |
| Silence Therapeutics | 238.06M |